Structure and Alternative Splicing of the Antisense FMR1 (ASFMR1) Gene.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 18 04 2022
accepted: 10 12 2022
pubmed: 5 1 2023
medline: 8 3 2023
entrez: 4 1 2023
Statut: ppublish

Résumé

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by an expansion of 55-200 CGG repeats (premutation) in the 5'-UTR of the FMR1 gene. Bidirectional transcription at FMR1 locus has been demonstrated and specific alternative splicing of the Antisense FMR1 (ASFMR1) gene has been proposed to have a contributing role in the pathogenesis of FXTAS. The structure of ASFMR1 gene is still uncharacterized and it is currently unknown how many isoforms of the gene are expressed and at what level in premutation carriers (PM) and if they may contribute to the premutation pathology. In this study, we characterized the ASFMR1 gene structure and the transcriptional landscape by using PacBio SMRT sequencing with target enrichment (IDT customized probe panel). We identified 45 ASFMR1 isoforms ranging in sizes from 523 bp to 6 Kb, spanning approximately 59 kb of genomic DNA. Multiplexing and sequencing of six human brain samples from PM samples and normal control (HC) were carried out on the PacBio Sequel platform. We validated the presence of these isoforms by qRT-PCR and Sanger sequencing and characterized the acceptor and donor splicing site consensus sequences. Consistent with previous studies conducted in other tissue types, we found a high expression of ASFMR1 isoform Iso131bp in brain samples of PM as compared to HC, while no differences in expression levels were observed for the newly identified isoforms IsoAS1 and IsoAS2. We investigated the role of the splicing regulatory protein Sam68 which we did not observe in the alternative splicing of the ASFMR1 gene. Our study provides a useful insight into the structure of ASFMR1 gene and transcriptional landscape along with the expression pattern of various newly identified novel isoforms and on their potential role in premutation pathology.

Identifiants

pubmed: 36598648
doi: 10.1007/s12035-022-03176-9
pii: 10.1007/s12035-022-03176-9
pmc: PMC10461537
mid: NIHMS1918757
doi:

Substances chimiques

Protein Isoforms 0
Fragile X Mental Retardation Protein 139135-51-6
FMR1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2051-2061

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD036071
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH078041
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110100
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Biomed Res Int. 2015;2015:528954
pubmed: 26273626
Int J Mol Sci. 2013 Nov 28;14(12):23402-19
pubmed: 24287914
EMBO J. 2010 Apr 7;29(7):1248-61
pubmed: 20186122
Nat Rev Neurol. 2016 Jul;12(7):403-12
pubmed: 27340021
Neurology. 2001 Jul 10;57(1):127-30
pubmed: 11445641
Sci Rep. 2020 Jul 6;10(1):11099
pubmed: 32632326
Neurol Genet. 2018 Jul 27;4(4):e246
pubmed: 30065951
Hum Mol Genet. 2007 Dec 15;16(24):3174-87
pubmed: 17921506
Nat Rev Genet. 2018 Dec;19(12):738-739
pubmed: 30341439
Cell Death Differ. 2016 Dec;23(12):1919-1929
pubmed: 27689872
Clin Chem. 2010 Mar;56(3):399-408
pubmed: 20056738
Mol Cell. 2016 Dec 15;64(6):1023-1034
pubmed: 27984743
Biochim Biophys Acta Gene Regul Mech. 2017 Nov;1860(11):1117-1126
pubmed: 28888471
J Mol Diagn. 2008 Jan;10(1):43-9
pubmed: 18165273
Am J Hum Genet. 2000 Jan;66(1):6-15
pubmed: 10631132
Am J Med Genet. 2000 Fall;97(3):195-203
pubmed: 11449488
Front Genet. 2019 Jul 09;10:584
pubmed: 31338105
Nat Genet. 1993 Jan;3(1):36-43
pubmed: 8490651
J Med Genet. 2015 Jan;52(1):42-52
pubmed: 25358671
Front Genet. 2018 Aug 22;9:302
pubmed: 30186307
Clin Genet. 2018 Feb;93(2):197-205
pubmed: 28617938
Genet Med. 2011 May;13(5):392-9
pubmed: 21270637
J Med Genet. 2014 May;51(5):309-18
pubmed: 24591415
Hum Genet. 2014 Jan;133(1):59-67
pubmed: 24005575
PLoS One. 2008 Jan 23;3(1):e1486
pubmed: 18213394
Nat Commun. 2020 May 11;11(1):2326
pubmed: 32393825
Front Mol Biosci. 2018 Feb 12;5:12
pubmed: 29484299
Genes (Basel). 2020 Nov 27;11(12):
pubmed: 33261024
Cell. 1991 May 31;65(5):905-14
pubmed: 1710175
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

Marwa Zafarullah (M)

Department of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Sacramento, CA, 95817, USA.

Jie Li (J)

Bioinformatics Core, Genome Center, University of California Davis, Davis, CA, 95616, USA.

Elizabeth Tseng (E)

Pacific Biosciences, Inc, Menlo Park, CA, 94025, USA.

Flora Tassone (F)

Department of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Sacramento, CA, 95817, USA. ftassone@ucdavis.edu.
MIND Institute, University of California Davis Medical Center, Sacramento, CA, 95817, USA. ftassone@ucdavis.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH